Trials / Conditions / Refractory Acute Myeloid Leukemia (AML)
Refractory Acute Myeloid Leukemia (AML)
5 registered clinical trials studyying Refractory Acute Myeloid Leukemia (AML) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia NCT07486726 | Shanghai Jiao Tong University School of Medicine | Phase 1 / Phase 2 |
| Not Yet Recruiting | CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS NCT07347418 | University of Colorado, Denver | Phase 1 |
| Active Not Recruiting | Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS NCT06846606 | Auron Therapeutics, Inc. | Phase 1 |
| Recruiting | A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) NCT06950034 | Solu Therapeutics, Inc | Phase 1 |
| Completed | A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome NCT03787498 | Opna Bio LLC | Phase 1 |